首页> 美国卫生研究院文献>Oncoscience >Improving patient classification and biomarker assessment using Gaussian Mixture Models and Bayes’ rule
【2h】

Improving patient classification and biomarker assessment using Gaussian Mixture Models and Bayes’ rule

机译:使用高斯混合模型和贝叶斯规则改善患者分类和生物标志物评估

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

In clinical research, determining cutoff values for continuous variables in test results remains challenging, particularly when considering candidate biomarkers or therapeutic targets for disease. Distribution of a continuous variable into two populations is known as dichotomization and has been commonly used in clinical studies. We recently reported a new method for determining multiple cutoffs for continuous variables. The development of this original approach was based on fitting Gaussian Mixture Models (GMM) onto real-world clinical data. We also explored how to leverage Bayesian probability to minimize uncertainty while classifying individual patients into respective subpopulations. In addition, we investigated the performance of the proposed method for the distribution of classical prognostic markers in breast cancer. Finally, we applied the proposed method to analyze a candidate marker and a target for cancer therapy. Here, we present an overview of this method and our prospects for its implementation in biomedical and clinical research.
机译:在临床研究中,确定测试结果中连续变量的临界值仍然具有挑战性,尤其是在考虑候选生物标志物或疾病的治疗靶标时。将连续变量分配到两个总体中被称为二分法,并且已在临床研究中广泛使用。我们最近报告了一种确定连续变量的多个临界值的新方法。这种原始方法的开发是基于将高斯混合模型(GMM)拟合到现实世界的临床数据上。我们还探讨了如何利用贝叶斯概率最大程度地减少不确定性,同时将各个患者分为不同的亚群。此外,我们调查了建议的方法在乳腺癌中分配经典预后指标的性能。最后,我们将提出的方法应用于分析癌症治疗的候选标记物和靶标。在这里,我们概述了这种方法及其在生物医学和临床研究中的应用前景。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号